Literature DB >> 16086627

Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.

Leslie Citrome, Jan Volavka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086627     DOI: 10.4088/jcp.v66n0818c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

1.  Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics.

Authors:  Christina Mangurian; Aishat Giwa; Erin Brosey; Martha Shumway; James Dilley; Elena Fuentes-Afflick; Eliseo J Pérez-Stable; Dean Schillinger
Journal:  J Am Board Fam Med       Date:  2019 May-Jun       Impact factor: 2.657

Review 2.  The vagus nerve and the inflammatory reflex--linking immunity and metabolism.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Rev Endocrinol       Date:  2012-12       Impact factor: 43.330

3.  Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance.

Authors:  Huqun Li; Shiyong Peng; Shihong Li; Shouqing Liu; Yifan Lv; Ni Yang; Liangyu Yu; Ya-Hui Deng; Zhongjian Zhang; Maosheng Fang; Yunxiang Huo; Ying Chen; Taohua Sun; Weiyong Li
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

4.  Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes.

Authors:  Seiichiro Tada; Masaki Okumura; Kenta Inoguchi; Satoshi Ninagawa; Misaki Kinoshita; Shingo Kanemura; Koshi Imami; Hajime Umezawa; Tokiro Ishikawa; Robert B Mackin; Seiji Torii; Yasushi Ishihama; Kenji Inaba; Takayuki Anazawa; Takahiko Nagamine; Kazutoshi Mori
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.